Literature DB >> 12505370

Regulation and quality control of herbal drugs in Korea.

Don Woong Choi1, Jong Hwan Kim, So Yean Cho, Dal Hwan Kim, Seung Yeup Chang.   

Abstract

Korea has a great diversity in resources of medicinal plants. The traditional herbal medicines and their preparations have been widely used in Korea as well as in China and Japan for thousands of years. One of the characteristics of Korean herbal medicine preparations is that all the herbal medicines are incorporated into an extractor at the same time and extracted with boiling water during the decoction process. In this process, a variety of interactions between the active components of several herbal medicines may occur. This is the main reason why quality control of oriental herbal drug is more difficult than that of western herbal drug. In this paper, we would like to present an overview of the characteristics of regulation and quality control of herbal medicines in Korea.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505370     DOI: 10.1016/s0300-483x(02)00487-0

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  14 in total

1.  Statistical quality control of total ash, acid-insoluble ash, loss on drying, and hazardous heavy metals contained in the component medicinal herbs of "Ssanghwatang", a widely used oriental formula in Korea.

Authors:  Donggyu Kim; Bogsoon Kim; Eunsun Yun; Junghun Kim; Youngzoo Chae; Seungkook Park
Journal:  J Nat Med       Date:  2012-03-15       Impact factor: 2.343

Review 2.  Development of Hazardous Materials Management Standard for Decoction Type of Personalized Herbal Medicine.

Authors:  Hye-In Jeong; Kyeong-Han Kim; Jae-Hee Won; Gi-Un Sung; Ji-Won Kim; Ji-Eun Han; Angela Dong-Min Sung; Eun-Jung Park; Soo-Hyun Sung
Journal:  J Pharmacopuncture       Date:  2020-06-30

3.  Legal regulations of complementary and alternative medicines in different countries.

Authors:  Shailendra Saraf
Journal:  Pharmacogn Rev       Date:  2012-07

4.  Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study.

Authors:  Mohamad Alameddine; Farah Naja; Sarah Abdel-Salam; Salwa Maalouf; Claudia Matta
Journal:  BMC Complement Altern Med       Date:  2011-08-28       Impact factor: 3.659

5.  So-Cheong-Ryong-Tang induces apoptosis through activation of the intrinsic and extrinsic apoptosis pathways, and inhibition of the PI3K/Akt signaling pathway in non-small-cell lung cancer A549 cells.

Authors:  Cheol Park; Su Hyun Hong; Gi-Young Kim; Yung Hyun Choi
Journal:  BMC Complement Altern Med       Date:  2015-04-10       Impact factor: 3.659

6.  BOKP: A DNA Barcode Reference Library for Monitoring Herbal Drugs in the Korean Pharmacopeia.

Authors:  Jinxin Liu; Linchun Shi; Jingyuan Song; Wei Sun; Jianping Han; Xia Liu; Dianyun Hou; Hui Yao; Mingyue Li; Shilin Chen
Journal:  Front Pharmacol       Date:  2017-12-19       Impact factor: 5.810

Review 7.  A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies.

Authors:  Kyungho Kim; Kwang-Il Park
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-03       Impact factor: 2.629

8.  Quality Control of Pharmacopuncture: A Comparative Study of Good Manufacturing Practice and External Herbal Dispensary Standards.

Authors:  Ji-Eun Han; Minjung Park; Tteul-E-Bom An; Jong-Hyun Park; Danny Oh; Kyeong Han Kim; Soo-Hyun Sung
Journal:  J Pharmacopuncture       Date:  2021-06-30

9.  Simultaneous determination of five major compounds in the traditional medicine Pyeongwee-San by high performance liquid chromatography-diode array detection and liquid chromatography-mass spectrometry/mass spectrometry.

Authors:  Bohyoung Lee; Jin Bae Weon; Bo-Ra Yun; Jiwoo Lee; Min Rye Eom; Choong Je Ma
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085

10.  Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis.

Authors:  Jong-Chan Jang; Kang Min Lee; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2016-05-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.